Iantrek Announces Positive 2-year Results of Efficacy and Safety of its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Glaucoma Patients
Iantrek Appoints Adam Szaronos as Chief Executive Officer
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Onkos Surgical® to Accelerate Commercialization of Novel Antibacterial Implant Technology
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies
Global Healthcare Exchange Enhances Automation, Data Analytics and Inventory Management Capabilities with Acquisition of Syft
Onkos Surgical Raises $15 Million in Series C Funding
Water Street Announces Strategic Investment in Pathnostics
